 | • レポートコード：QYR9N8115 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、サラセミアのグローバル市場について調査・分析したレポートで、種類別（病院、診療所、研究所、実験室）、用途別（ブルーバードバイオ株式会社、株式会社アクセロンファーマ、セルジーン株式会社、グラクソスミスクライン社、インサイト社（株）、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・サラセミアの世界市場規模 ・主要企業別市場シェア ・サラセミアの世界市場規模：種類別（病院、診療所、研究所、実験室） ・サラセミアの世界市場規模：用途別（ブルーバードバイオ株式会社、株式会社アクセロンファーマ、セルジーン株式会社、グラクソスミスクライン社、インサイト社（株）、その他） ・サラセミアのアメリカ市場規模（種類別、用途別） ・サラセミアのヨーロッパ市場規模（種類別、用途別） ・サラセミアの中国市場規模（種類別、用途別） ・サラセミアの日本市場規模（種類別、用途別） ・サラセミアの東南アジア市場規模（種類別、用途別） ・サラセミアのインド市場規模（種類別、用途別） ・サラセミアの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・サラセミアの世界市場予測（2019年-2025年） ・サラセミアの地域別市場予測（2019年-2025年） ... |
In 2018, the global Thalassemia market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Thalassemia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thalassemia development in United States, Europe and China.
The key players covered in this study
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Market segment by Type, the product can be split into
Iron Chelating Drugs
Others
Market segment by Application, split into
Hospital
Clinic
Research Institute
Laboratories
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Thalassemia status, future forecast, growth opportunity, key market and key players.
To present the Thalassemia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Thalassemia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thalassemia Market Size Growth Rate by Type (2014-2025)
1.4.2 Iron Chelating Drugs
1.4.3 Others
1.5 Market by Application
1.5.1 Global Thalassemia Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Thalassemia Market Size
2.2 Thalassemia Growth Trends by Regions
2.2.1 Thalassemia Market Size by Regions (2014-2025)
2.2.2 Thalassemia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Thalassemia Market Size by Manufacturers
3.1.1 Global Thalassemia Revenue by Manufacturers (2014-2019)
3.1.2 Global Thalassemia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
3.2 Thalassemia Key Players Head office and Area Served
3.3 Key Players Thalassemia Product/Solution/Service
3.4 Date of Enter into Thalassemia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Thalassemia Market Size by Type (2014-2019)
4.2 Global Thalassemia Market Size by Application (2014-2019)
5 United States
5.1 United States Thalassemia Market Size (2014-2019)
5.2 Thalassemia Key Players in United States
5.3 United States Thalassemia Market Size by Type
5.4 United States Thalassemia Market Size by Application
6 Europe
6.1 Europe Thalassemia Market Size (2014-2019)
6.2 Thalassemia Key Players in Europe
6.3 Europe Thalassemia Market Size by Type
6.4 Europe Thalassemia Market Size by Application
7 China
7.1 China Thalassemia Market Size (2014-2019)
7.2 Thalassemia Key Players in China
7.3 China Thalassemia Market Size by Type
7.4 China Thalassemia Market Size by Application
8 Japan
8.1 Japan Thalassemia Market Size (2014-2019)
8.2 Thalassemia Key Players in Japan
8.3 Japan Thalassemia Market Size by Type
8.4 Japan Thalassemia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Thalassemia Market Size (2014-2019)
9.2 Thalassemia Key Players in Southeast Asia
9.3 Southeast Asia Thalassemia Market Size by Type
9.4 Southeast Asia Thalassemia Market Size by Application
10 India
10.1 India Thalassemia Market Size (2014-2019)
10.2 Thalassemia Key Players in India
10.3 India Thalassemia Market Size by Type
10.4 India Thalassemia Market Size by Application
11 Central & South America
11.1 Central & South America Thalassemia Market Size (2014-2019)
11.2 Thalassemia Key Players in Central & South America
11.3 Central & South America Thalassemia Market Size by Type
11.4 Central & South America Thalassemia Market Size by Application
12 International Players Profiles
12.1 Bluebird bio, Inc.
12.1.1 Bluebird bio, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Thalassemia Introduction
12.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2014-2019)
12.1.5 Bluebird bio, Inc. Recent Development
12.2 Acceleron Pharma, Inc.
12.2.1 Acceleron Pharma, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Thalassemia Introduction
12.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2014-2019)
12.2.5 Acceleron Pharma, Inc. Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Thalassemia Introduction
12.3.4 Celgene Corporation Revenue in Thalassemia Business (2014-2019)
12.3.5 Celgene Corporation Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Thalassemia Introduction
12.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2014-2019)
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Incyte Corporation
12.5.1 Incyte Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Thalassemia Introduction
12.5.4 Incyte Corporation Revenue in Thalassemia Business (2014-2019)
12.5.5 Incyte Corporation Recent Development
12.6 Gamida Cell
12.6.1 Gamida Cell Company Details
12.6.2 Company Description and Business Overview
12.6.3 Thalassemia Introduction
12.6.4 Gamida Cell Revenue in Thalassemia Business (2014-2019)
12.6.5 Gamida Cell Recent Development
12.7 Kiadis Pharma
12.7.1 Kiadis Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Thalassemia Introduction
12.7.4 Kiadis Pharma Revenue in Thalassemia Business (2014-2019)
12.7.5 Kiadis Pharma Recent Development
12.8 La Jolla Pharmaceutical Company
12.8.1 La Jolla Pharmaceutical Company Company Details
12.8.2 Company Description and Business Overview
12.8.3 Thalassemia Introduction
12.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2014-2019)
12.8.5 La Jolla Pharmaceutical Company Recent Development
12.9 IONIS Pharmaceuticals
12.9.1 IONIS Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Thalassemia Introduction
12.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2014-2019)
12.9.5 IONIS Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Thalassemia Key Market Segments
Table Key Players Thalassemia Covered
Table Global Thalassemia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Thalassemia Market Size Market Share by Type 2014-2025
Figure Iron Chelating Drugs Figures
Table Key Players of Iron Chelating Drugs
Figure Others Figures
Table Key Players of Others
Table Global Thalassemia Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Research Institute Case Studies
Figure Laboratories Case Studies
Figure Thalassemia Report Years Considered
Table Global Thalassemia Market Size 2014-2025 (Million US$)
Figure Global Thalassemia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Thalassemia Market Size by Regions 2014-2025 (Million US$)
Table Global Thalassemia Market Size by Regions 2014-2019 (Million US$)
Table Global Thalassemia Market Share by Regions 2014-2019
Figure Global Thalassemia Market Share by Regions 2014-2019
Figure Global Thalassemia Market Share by Regions 2019
Table Market Top Trends
Table Global Thalassemia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Thalassemia Market Share by Manufacturers (2014-2019)
Figure Global Thalassemia Market Share by Manufacturers in 2018
Table Global Thalassemia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Thalassemia Product/Solution/Service
Table Date of Enter into Thalassemia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Thalassemia Market Size by Type (2014-2019) (Million US$)
Table Global Thalassemia Market Size Share by Type (2014-2019)
Figure Global Thalassemia Market Size Market Share by Type (2014-2019)
Table Global Thalassemia Market Size by Application (2014-2019) (Million US$)
Table Global Thalassemia Market Size Share by Application (2014-2019)
Figure Global Thalassemia Market Size Market Share by Application (2014-2019)
Figure Global Thalassemia Revenue Market Share by Application in 2018
Figure United States Thalassemia Market Size 2014-2019 (Million US$)
Table United States Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table United States Key Players Thalassemia Market Share (2018-2019)
Table United States Thalassemia Market Size by Type (2014-2019) (Million US$)
Table United States Thalassemia Market Share by Type (2014-2019)
Table United States Thalassemia Market Size by Application (2014-2019) (Million US$)
Table United States Thalassemia Market Share by Application (2014-2019)
Figure Europe Thalassemia Market Size 2014-2019 (Million US$)
Table Europe Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table Europe Key Players Thalassemia Market Share (2018-2019)
Table Europe Thalassemia Market Size by Type (2014-2019) (Million US$)
Table Europe Thalassemia Market Share by Type (2014-2019)
Table Europe Thalassemia Market Size by Application (2014-2019) (Million US$)
Table Europe Thalassemia Market Share by Application (2014-2019)
Figure China Thalassemia Market Size 2014-2019 (Million US$)
Table China Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table China Key Players Thalassemia Market Share (2018-2019)
Table China Thalassemia Market Size by Type (2014-20189) (Million US$)
Table China Thalassemia Market Share by Type (2014-2019)
Table China Thalassemia Market Size by Application (2014-2019) (Million US$)
Table China Thalassemia Market Share by Application (2014-2019)
Figure Japan Thalassemia Market Size 2014-2019 (Million US$)
Table Japan Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table Japan Key Players Thalassemia Market Share (2018-2019)
Table Japan Thalassemia Market Size by Type (2014-2019) (Million US$)
Table Japan Thalassemia Market Share by Type (2014-2019)
Table Japan Thalassemia Market Size by Application (2014-2019) (Million US$)
Table Japan Thalassemia Market Share by Application (2014-2019)
Figure Southeast Asia Thalassemia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Thalassemia Market Share (2018-2019)
Table Southeast Asia Thalassemia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Thalassemia Market Share by Type (2014-2019)
Table Southeast Asia Thalassemia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Thalassemia Market Share by Application (2014-2019)
Figure India Thalassemia Market Size 2014-2019 (Million US$)
Table India Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table India Key Players Thalassemia Market Share (2018-2019)
Table India Thalassemia Market Size by Type (2014-2019) (Million US$)
Table India Thalassemia Market Share by Type (2014-2019)
Table India Thalassemia Market Size by Application (2014-2019) (Million US$)
Table India Thalassemia Market Share by Application (2014-2019)
Figure Central & South America Thalassemia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Thalassemia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Thalassemia Market Share (2018-2019)
Table Central & South America Thalassemia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Thalassemia Market Share by Type (2014-2019)
Table Central & South America Thalassemia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Thalassemia Market Share by Application (2014-2019)
Table Bluebird bio, Inc. Company Details
Table Bluebird bio, Inc. Revenue in Thalassemia Business (2014-2019) (Million US$)
Figure Bluebird bio, Inc. Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Bluebird bio, Inc. Recent Development
Table Acceleron Pharma, Inc. Company Details
Table Acceleron Pharma, Inc. Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure Acceleron Pharma, Inc. Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Acceleron Pharma, Inc. Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Celgene Corporation Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Thalassemia Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Incyte Corporation Company Details
Table Incyte Corporation Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure Incyte Corporation Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Incyte Corporation Recent Development
Table Gamida Cell Company Details
Table Gamida Cell Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure Gamida Cell Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Gamida Cell Recent Development
Table Kiadis Pharma Company Details
Table Kiadis Pharma Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2014-2019)
Table Kiadis Pharma Recent Development
Table La Jolla Pharmaceutical Company Company Details
Table La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure La Jolla Pharmaceutical Company Revenue Growth Rate in Thalassemia Business (2014-2019)
Table La Jolla Pharmaceutical Company Recent Development
Table IONIS Pharmaceuticals Company Details
Table IONIS Pharmaceuticals Revenue in Thalassemia Business (2014-2019)(Million US$)
Figure IONIS Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2014-2019)
Table IONIS Pharmaceuticals Recent Development
Table Global Thalassemia Market Size by Regions (Million US$) 2019-2025
Figure Global Thalassemia Market Size Share by Regions (2019-2025)
Figure Global Thalassemia Market Size Share by Regions in 2025
Figure United States Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure China Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure India Thalassemia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Thalassemia Market Size Forecast (2019-2025)(Million USD)
Table Global Thalassemia Market Size by Product (2019-2025) (Million US$)
Figure Global Thalassemia Market Size by Product (2019-2025)
Figure Global Thalassemia Market Size by Product in 2025
Table Global Thalassemia Market Size by Application (2019-2025) (Million US$)
Figure Global Thalassemia Market Size by Application (2019-2025)
Figure Global Thalassemia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の鉄剤市場：市場規模・現状・予測 Iron is required to transport oxygen through haemoglobin in red blood cells (RBCs) and oxidize cells through cytochrome. Iron deficiency is a common cause of anaemia. Iron drugs are used to treat people with iron deficiency.In terms of geographic regions, the North Americas accounted for the major s…- 世界の脳幹オーラ薬と片頭痛市場：市場規模・現状・予測 A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occu…
- 世界の一般麻酔薬市場：市場規模・現状・予測 General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure.In 2018, the global General Anaesthesia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx%…
- 世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…